Healthcare provider profile · identity verified

Steven Sainsbury, MD

General Practice · SAN LUIS OBISPO, CA · NPI 1679521256

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	394	68
Quetiapine Fumarate	Quetiapine Fumarate	305	54
Escitalopram Oxalate	Escitalopram Oxalate	255	38
Furosemide	Furosemide	251	40
Atorvastatin Calcium	Atorvastatin Calcium	200	34
Amlodipine Besylate	Amlodipine Besylate	195	37
Pantoprazole Sodium	Pantoprazole Sodium	194	28
Losartan Potassium	Losartan Potassium	179	29
Metoprolol Succinate	Metoprolol Succinate	177	26
Omeprazole	Omeprazole	159	32
Trazodone Hcl	Trazodone Hcl	141	28
Gabapentin	Gabapentin	115	19
Lorazepam	Lorazepam	99	37
Lisinopril	Lisinopril	97	20
Eliquis	Apixaban	96	18
Donepezil Hcl	Donepezil Hcl	90	17
Mirtazapine	Mirtazapine	77	suppressed
Potassium Chloride	Potassium Chloride	72	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	69	17
Cefuroxime	Cefuroxime Axetil	67	37
Metformin Hcl	Metformin Hcl	65	suppressed
Simvastatin	Simvastatin	65	13
Tamsulosin Hcl	Tamsulosin Hcl	63	15
Metoprolol Tartrate	Metoprolol Tartrate	61	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	60	suppressed
Finasteride	Finasteride	59	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	57	suppressed
Aripiprazole	Aripiprazole	56	suppressed
Alendronate Sodium	Alendronate Sodium	53	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	50	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	50	suppressed
Xarelto	Rivaroxaban	50	suppressed
Clopidogrel	Clopidogrel Bisulfate	48	suppressed
Latanoprost	Latanoprost	46	11
Raloxifene Hcl	Raloxifene Hcl	46	suppressed
Cephalexin	Cephalexin	45	34
Famotidine	Famotidine	45	suppressed
Sertraline Hcl	Sertraline Hcl	43	suppressed
Prednisone	Prednisone	42	11
Memantine Hcl	Memantine Hcl	41	suppressed
Carvedilol	Carvedilol	39	suppressed
Midodrine Hcl	Midodrine Hcl	38	suppressed
Enalapril Maleate	Enalapril Maleate	36	suppressed
Fluticasone Propionate	Fluticasone Propionate	36	14
Myrbetriq	Mirabegron	36	suppressed
Ondansetron Hcl	Ondansetron Hcl	35	suppressed
Pravastatin Sodium	Pravastatin Sodium	35	suppressed
Bupropion Xl	Bupropion Hcl	34	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	34	16
Alprazolam	Alprazolam	33	suppressed
Meloxicam	Meloxicam	32	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	31	25
Methenamine Hippurate	Methenamine Hippurate	29	suppressed
Morphine Sulfate	Morphine Sulfate	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Divalproex Sodium	Divalproex Sodium	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	21
Levetiracetam	Levetiracetam	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Enulose	Lactulose	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	23	suppressed
Hydrocortisone	Hydrocortisone	22	suppressed
Lamotrigine	Lamotrigine	22	suppressed
Tramadol Hcl	Tramadol Hcl	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Allopurinol	Allopurinol	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Metronidazole	Metronidazole	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	17	suppressed
Duloxetine Hcl	Duloxetine Hcl	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Jardiance	Empagliflozin	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Atenolol	Atenolol	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	suppressed
Levofloxacin	Levofloxacin	15	12
Rivastigmine	Rivastigmine	15	suppressed
Sotalol	Sotalol Hcl	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Estradiol	Estradiol	14	suppressed
Methimazole	Methimazole	14	suppressed
Ozempic	Semaglutide	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Temazepam	Temazepam	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Glipizide	Glipizide	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Aliskiren	Aliskiren Hemifumarate	12	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Entacapone	Entacapone	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Zonisamide	Zonisamide	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Cyclosporine	Cyclosporine	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Nystatin	Nystatin	11	suppressed
Risperidone	Risperidone	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error